UBE2C
UBE2C (ubiquitin conjugating enzyme E2 C, also known as UBCH10) is an E2 ubiquitin-conjugating enzyme that accepts ubiquitin from the E1 complex and attaches it to other proteins. It is an essential factor for the anaphase promoting complex/cyclosome during mitosis. Browse Assay Genie's current range of UBE2C research reagents below, or read on for the biology behind the target.
UBE2C accepts ubiquitin from the E1 complex and catalyses its covalent attachment to other proteins. In vitro it catalyses 'Lys-11'- and 'Lys-48'-linked polyubiquitination. Its best-defined role is as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. UBE2C acts by initiating 'Lys-11'-linked polyubiquitin chains on APC/C substrates, which leads to their degradation by the proteasome and promotes mitotic exit.
Protein modification with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. It involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes and ubiquitin-protein ligases. The UBE2C gene encodes a member of the E2 ubiquitin-conjugating enzyme family, and the encoded protein is required for the destruction of mitotic cyclins and for cell cycle progression. Multiple transcript variants encoding different isoforms have been reported, and pseudogenes of the gene have been defined on several other chromosomes.
UBE2C belongs to the HGNC gene group of ubiquitin conjugating enzymes E2 and is catalogued under the alias UBCH10 and the previous name ubiquitin-conjugating enzyme E2C. The mouse ortholog is Ube2c. NCBI Gene notes that the protein may be involved in cancer progression, which makes the UBE2C protein a frequent subject in cell cycle and oncology studies.
UBE2C is required for the destruction of mitotic cyclins and for cell cycle progression, making it central to studies of mitotic exit.
As an E2 enzyme that accepts ubiquitin from E1, UBE2C helps define how ubiquitin transfer and chain formation lead to proteasomal degradation.
UBE2C is an essential factor of the anaphase promoting complex/cyclosome, initiating Lys-11-linked polyubiquitin chains on APC/C substrates.
NCBI Gene reports that UBE2C may be involved in cancer progression, supporting its study in tumour cell proliferation.
UBE2C is an E2 ubiquitin-conjugating enzyme that accepts ubiquitin from the E1 complex and catalyses its attachment to other proteins. It is essential for the anaphase promoting complex/cyclosome, initiating Lys-11-linked polyubiquitin chains on substrates so they are degraded by the proteasome and mitosis can be exited.
UBE2C is also known as UBCH10, and its previous HGNC name was ubiquitin-conjugating enzyme E2C. UniProt lists it as ubiquitin-conjugating enzyme E2 C. NCBI Gene notes that multiple transcript variants encoding different isoforms have been found for the gene.
A mouse ortholog, Ube2c, is recorded for this gene. NCBI Gene states that the encoded protein may be involved in cancer progression. Check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.
Other E2 ubiquitin-conjugating enzymes and related ubiquitin ligases involved in protein ubiquitination.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00762; product specifications from Assay Genie datasheets.